Pure Bioscience's total assets for Q3 2025 were $1.06M, an increase of 84.15% from the previous quarter. PURE total liabilities were $5.87M for the fiscal quarter, a 21.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.